TNF Inhibitors Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064079
  • May 2021
  • Pharmaceuticals
  • 134 Pages
The TNF Inhibitors Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Johnson and Johnson Services, Inc, Pfizer Inc., Merck and Co., Inc., Novartis AG, Amgen Inc, UCB S.A., AbbVie Inc, Sanofi, Bristol-myers squibb, Shanghai Pharmaceuticals, HanAll Biopharma, Intas Pharmaceuticals, LEO Pharma, LG Life Sciences, MedImmune
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The TNF Inhibitors market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the TNF Inhibitors market is expected to attain Pre COVID-19 levels by mid-2022.

TNF Inhibitors Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the TNF Inhibitors market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

TNF Inhibitors Market Competitive and Premeditated Analysis
In the TNF Inhibitors report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the TNF Inhibitors research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global TNF Inhibitors Market:
The TNF Inhibitors market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Johnson and Johnson Services, Inc, Pfizer Inc., Merck and Co., Inc., Novartis AG, Amgen Inc, UCB S.A., AbbVie Inc, Sanofi, Bristol-myers squibb, Shanghai Pharmaceuticals, HanAll Biopharma, Intas Pharmaceuticals, LEO Pharma, LG Life Sciences, MedImmune

The TNF Inhibitors market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

TNF Inhibitors Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the TNF Inhibitors market:
By Drug class
Remicade
Enbrel
Humira
Cimzia
Simponi
Others
Indication
Rheumatoid Arthritis
Crohns Disease
Psoriasis
Others
Mode of Administration
Injectables
Orals
Others
Distribution Channel
Hospital Pharmacies
Specialty Pharmacies
Online Pharmacies
others

Regional Analysis of the TNF Inhibitors market:
The TNF Inhibitors market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the TNF Inhibitors report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire TNF Inhibitors market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the TNF Inhibitors market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the TNF Inhibitors market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the TNF Inhibitors market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the TNF Inhibitors market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the TNF Inhibitors market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the TNF Inhibitors market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the TNF Inhibitors market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Johnson and Johnson Services, Inc
  • Pfizer Inc.
  • Merck and Co., Inc.
  • Novartis AG
  • Amgen Inc
  • UCB S.A.
  • AbbVie Inc
  • Sanofi
  • Bristol-myers squibb
  • Shanghai Pharmaceuticals
  • HanAll Biopharma
  • Intas Pharmaceuticals
  • LEO Pharma
  • LG Life Sciences
  • MedImmune
  • Remicade
  • Enbrel
  • Humira
  • Cimzia
  • Simponi
  • Others
  • Hospital Pharmacies
  • Specialty Pharmacies
  • Online Pharmacies
  • others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global TNF Inhibitors Market Snapshot
          2.1.1. Global TNF Inhibitors Market By Drug class,2019
               2.1.1.1.Remicade
               2.1.1.2.Enbrel
               2.1.1.3.Humira
               2.1.1.4.Cimzia
               2.1.1.5.Simponi
               2.1.1.6.Others
          2.1.2. Global TNF Inhibitors Market By Distribution Channel,2019
               2.1.2.1.Hospital Pharmacies
               2.1.2.2.Specialty Pharmacies
               2.1.2.3.Online Pharmacies
               2.1.2.4.others
          2.1.3. Global TNF Inhibitors Market By End-use,2019
          2.1.4. Global TNF Inhibitors Market By Geography,2019

3. Global TNF Inhibitors Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global TNF Inhibitors Market Size (US$), By Drug class, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Drug class, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Drug class, 2020
     4.2. Global TNF Inhibitors Market Size (US$), By Drug class, 2018 – 2028

5. Global TNF Inhibitors Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global TNF Inhibitors Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global TNF Inhibitors Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global TNF Inhibitors Market Size (US$), By End-use, 2018 – 2028

7. Global TNF Inhibitors Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America TNF Inhibitors Market Analysis, 2018 – 2028 
          7.2.1. North America TNF Inhibitors Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America TNF Inhibitors Market Size (US$), By Drug class, 2018 – 2028
          7.2.3. North America TNF Inhibitors Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America TNF Inhibitors Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe TNF Inhibitors Market Analysis, 2018 – 2028 
          7.3.1.  Europe TNF Inhibitors Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe TNF Inhibitors Market Size (US$), By Drug class, 2018 – 2028
          7.3.3. Europe TNF Inhibitors Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe TNF Inhibitors Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific TNF Inhibitors Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific TNF Inhibitors Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific TNF Inhibitors Market Size (US$), By Drug class, 2018 – 2028
          7.4.3. Asia Pacific TNF Inhibitors Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific TNF Inhibitors Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America TNF Inhibitors Market Analysis, 2018 – 2028 
          7.5.1.  Latin America TNF Inhibitors Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America TNF Inhibitors Market Size (US$), By Drug class, 2018 – 2028
          7.5.3. Latin America TNF Inhibitors Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America TNF Inhibitors Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) TNF Inhibitors Market Analysis, 2018 – 2028 
          7.6.1.  MEA TNF Inhibitors Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA TNF Inhibitors Market Size (US$), By Drug class, 2018 – 2028
          7.6.3. MEA TNF Inhibitors Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA TNF Inhibitors Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key TNF Inhibitors Providers
        8.4.1 Johnson and Johnson Services, Inc
                8.4.1.1 Business Description
                8.4.1.2 Johnson and Johnson Services, Inc Geographic Operations
                8.4.1.3 Johnson and Johnson Services, Inc Financial Information
                8.4.1.4 Johnson and Johnson Services, Inc Product Positions/Portfolio
                8.4.1.5 Johnson and Johnson Services, Inc Key Developments
        8.4.2 Pfizer Inc.
                8.4.2.1 Business Description
                8.4.2.2 Pfizer Inc. Geographic Operations
                8.4.2.3 Pfizer Inc. Financial Information
                8.4.2.4 Pfizer Inc. Product Positions/Portfolio
                8.4.2.5 Pfizer Inc. Key Developments
        8.4.3 Merck and Co., Inc.
                8.4.3.1 Business Description
                8.4.3.2 Merck and Co., Inc. Geographic Operations
                8.4.3.3 Merck and Co., Inc. Financial Information
                8.4.3.4 Merck and Co., Inc. Product Positions/Portfolio
                8.4.3.5 Merck and Co., Inc. Key Developments
        8.4.4 Novartis AG
                8.4.4.1 Business Description
                8.4.4.2 Novartis AG Geographic Operations
                8.4.4.3 Novartis AG Financial Information
                8.4.4.4 Novartis AG Product Positions/Portfolio
                8.4.4.5 Novartis AG Key Developments
        8.4.5 Amgen Inc
                8.4.5.1 Business Description
                8.4.5.2 Amgen Inc Geographic Operations
                8.4.5.3 Amgen Inc Financial Information
                8.4.5.4 Amgen Inc Product Positions/Portfolio
                8.4.5.5 Amgen Inc Key Developments
        8.4.6 UCB S.A.
                8.4.6.1 Business Description
                8.4.6.2 UCB S.A. Geographic Operations
                8.4.6.3 UCB S.A. Financial Information
                8.4.6.4 UCB S.A. Product Positions/Portfolio
                8.4.6.5 UCB S.A. Key Developments
        8.4.7 AbbVie Inc
                8.4.7.1 Business Description
                8.4.7.2 AbbVie Inc Geographic Operations
                8.4.7.3 AbbVie Inc Financial Information
                8.4.7.4 AbbVie Inc Product Positions/Portfolio
                8.4.7.5 AbbVie Inc Key Developments
        8.4.8 Sanofi
                8.4.8.1 Business Description
                8.4.8.2 Sanofi Geographic Operations
                8.4.8.3 Sanofi Financial Information
                8.4.8.4 Sanofi Product Positions/Portfolio
                8.4.8.5 Sanofi Key Developments
        8.4.9 Bristol-myers squibb
                8.4.9.1 Business Description
                8.4.9.2 Bristol-myers squibb Geographic Operations
                8.4.9.3 Bristol-myers squibb Financial Information
                8.4.9.4 Bristol-myers squibb Product Positions/Portfolio
                8.4.9.5 Bristol-myers squibb Key Developments
        8.4.10 Shanghai Pharmaceuticals
                8.4.10.1 Business Description
                8.4.10.2 Shanghai Pharmaceuticals Geographic Operations
                8.4.10.3 Shanghai Pharmaceuticals Financial Information
                8.4.10.4 Shanghai Pharmaceuticals Product Positions/Portfolio
                8.4.10.5 Shanghai Pharmaceuticals Key Developments
        8.4.11 HanAll Biopharma
                8.4.11.1 Business Description
                8.4.11.2 HanAll Biopharma Geographic Operations
                8.4.11.3 HanAll Biopharma Financial Information
                8.4.11.4 HanAll Biopharma Product Positions/Portfolio
                8.4.11.5 HanAll Biopharma Key Developments
        8.4.12 Intas Pharmaceuticals
                8.4.12.1 Business Description
                8.4.12.2 Intas Pharmaceuticals Geographic Operations
                8.4.12.3 Intas Pharmaceuticals Financial Information
                8.4.12.4 Intas Pharmaceuticals Product Positions/Portfolio
                8.4.12.5 Intas Pharmaceuticals Key Developments
        8.4.13 LEO Pharma
                8.4.13.1 Business Description
                8.4.13.2 LEO Pharma Geographic Operations
                8.4.13.3 LEO Pharma Financial Information
                8.4.13.4 LEO Pharma Product Positions/Portfolio
                8.4.13.5 LEO Pharma Key Developments
        8.4.14 LG Life Sciences
                8.4.14.1 Business Description
                8.4.14.2 LG Life Sciences Geographic Operations
                8.4.14.3 LG Life Sciences Financial Information
                8.4.14.4 LG Life Sciences Product Positions/Portfolio
                8.4.14.5 LG Life Sciences Key Developments
        8.4.15 MedImmune
                8.4.15.1 Business Description
                8.4.15.2 MedImmune Geographic Operations
                8.4.15.3 MedImmune Financial Information
                8.4.15.4 MedImmune Product Positions/Portfolio
                8.4.15.5 MedImmune Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global TNF Inhibitors Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America TNF Inhibitors Market Revenue, By Drug class, 2018 – 2028 (US$ Mn) 
TABLE 5 North America TNF Inhibitors Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America TNF Inhibitors Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe TNF Inhibitors Market Revenue, By Drug class, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe TNF Inhibitors Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe TNF Inhibitors Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific TNF Inhibitors Market Revenue, By Drug class, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific TNF Inhibitors Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific TNF Inhibitors Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America TNF Inhibitors Market Revenue, By Drug class, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America TNF Inhibitors Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America TNF Inhibitors Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA TNF Inhibitors Market Revenue, By Drug class, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA TNF Inhibitors Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA TNF Inhibitors Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global TNF Inhibitors: Market Segmentation 
FIG. 2 Global TNF Inhibitors Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global TNF Inhibitors Market, By Drug class, 2019 (US$ Mn) 
FIG. 5 Global TNF Inhibitors Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global TNF Inhibitors Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global TNF Inhibitors Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global TNF Inhibitors Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key TNF Inhibitors Providers, 2019
FIG. 11 Global TNF Inhibitors Market Revenue Contribution, By Drug class, 2019 & 2028 (Value %) 
FIG. 12 Global TNF Inhibitors Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global TNF Inhibitors Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America TNF Inhibitors Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe TNF Inhibitors Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific TNF Inhibitors Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America TNF Inhibitors Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA TNF Inhibitors Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the TNF Inhibitors market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global TNF Inhibitors Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America TNF Inhibitors Market Value, By Segment1, 2018 – 2028
TABLE  North America TNF Inhibitors Market Value, By Segment2, 2018 – 2028
TABLE  North America TNF Inhibitors Market Value, By Country, 2018 – 2028
TABLE  Europe TNF Inhibitors Market Value, By Segment1, 2018 – 2028
TABLE  Europe TNF Inhibitors Market Value, By Segment2, 2018 – 2028
TABLE  Europe TNF Inhibitors Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific TNF Inhibitors Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific TNF Inhibitors Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific TNF Inhibitors Market Value, By Country, 2018 – 2028
TABLE  Latin America TNF Inhibitors Market Value, By Segment1, 2018 – 2028
TABLE  Latin America TNF Inhibitors Market Value, By Segment2, 2018 – 2028
TABLE  Latin America TNF Inhibitors Market Value, By Country, 2018 – 2028
TABLE  MEA TNF Inhibitors Market Value, By Segment1, 2018 – 2028
TABLE  MEA TNF Inhibitors Market Value, By Segment2, 2018 – 2028
TABLE  MEA TNF Inhibitors Market Value, By Country, 2018 – 2028
TABLE  Johnson and Johnson Services, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck and Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Amgen Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  UCB S.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AbbVie Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol-myers squibb: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Shanghai Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  HanAll Biopharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Intas Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  LEO Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  LG Life Sciences: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  MedImmune: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global TNF Inhibitors Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global TNF Inhibitors Market, By Segment1, 2019 (US$ Mn)
FIG.  Global TNF Inhibitors Market, By Segment2, 2019 (US$ Mn)
FIG.  Global TNF Inhibitors Market, By Geography, 2019 (US$ Mn)
FIG.  Global TNF Inhibitors Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key TNF Inhibitors Providers, 2016
FIG.  Global TNF Inhibitors Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Enbrel Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Humira Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Cimzia Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Simponi Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global TNF Inhibitors Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Specialty Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  France TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  China TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  India TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA TNF Inhibitors Market Value, 2018 – 2028, (US$ Mn)